The regular loss of 16q in these and other breast tumours implies the presence of relevant tumour-suppressor gene(s) on 16q; although various tumour-suppressor genes have been implicated, for example CTCF (Filipopva et al, 1998), none have been proven as pathogenic. This evidence concerns the gene CTCF and neoplasm.